A panel of international leaders in neuroscience, artificial intelligence and [...]

Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]

A gene therapy developed by uniQure appears to slow progression [...]

Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

N4 Pharma plc, the UK biotech developing its proprietary Nuvec® [...]

Kairos Pharma has announced encouraging interim efficacy results from its [...]

Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]

Carolina Molecular and Astoriom have formed a strategic partnership to [...]